Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.
NCT05510934 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2024-08-21
Summary
This study aims to assess the feasibility of a shared-care model for low-risk differentiated thyroid cancer (DTC) patients, primary care practitioners (PCPs) and the tertiary care center utilizing a digital health-based thyroid cancer assessment reminder system (TCARS) in Medable with an expedited referral to specialists for rapid assessment in case of a concern of recurrence.
Conditions
- Low Risk Differentiated Thyroid Cancer
Interventions
- BEHAVIORAL
-
Shared-care model
A Shared care follow-up strategy involving patients, PCPs and specialists that uses an automated reminder system (TCARS).
Sponsors & Collaborators
-
Nova Scotia Health Authority
lead OTHER
Principal Investigators
-
Syed A. Imran, Dr. · Nova Scotia Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-30
- Primary Completion
- 2025-09-30
- Completion
- 2025-12-30
Countries
- Canada
Study Locations
More Related Trials
-
Active Surveillance of Papillary Thyroid Microcarcinoma
NCT02609685 ·Status: RECRUITING ·Phase: NA
-
HRQOL in Thyroid Cancer and Thyroid Tumours
NCT03676348 ·Status: RECRUITING
-
Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer
NCT01083550 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer
NCT00604318 ·Status: COMPLETED ·Phase: PHASE4
-
99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients
NCT03065218 ·Status: TERMINATED ·Phase: PHASE4
-
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
NCT06853925 ·Status: RECRUITING ·Phase: NA
-
Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients
NCT03757637 ·Status: RECRUITING ·Phase: NA
-
Primary Care Transfer for Thyroid Cancer Patients
NCT03794375 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
NCT01837745 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
NCT02418247 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma
NCT01974284 ·Status: TERMINATED ·Phase: NA
-
Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
NCT00095836 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
NCT04868045 ·Status: WITHDRAWN ·Phase: PHASE1
-
The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study
NCT01792492 ·Status: COMPLETED
-
Psycho-oncological Intervention Through Counselling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine
NCT05054634 ·Status: COMPLETED
-
Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
NCT04290663 ·Status: RECRUITING ·Phase: PHASE3
-
Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients
NCT00435851 ·Status: UNKNOWN ·Phase: PHASE3
-
Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules
NCT01401855 ·Status: COMPLETED
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
NCT05733013 ·Status: RECRUITING
-
Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3
NCT03488134 ·Status: COMPLETED
-
Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences
NCT05819593 ·Status: NOT_YET_RECRUITING
-
Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
NCT00389441 ·Status: COMPLETED ·Phase: PHASE2
-
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
NCT03624751 ·Status: ACTIVE_NOT_RECRUITING
-
Decision Aid and Thyroid Nodules Management
NCT05264857 ·Status: RECRUITING ·Phase: NA
-
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
NCT05024929 ·Status: RECRUITING